Application of urea channel protein inhibitors

A compound and selected technology, applied in the field of urea channel protein inhibitors, can solve the problem of no increase in urine osmotic pressure

Inactive Publication Date: 2017-08-11
PEKING UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And after 5 days of strictly controlled fluid intake, their urine osmolality did not increase

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of urea channel protein inhibitors
  • Application of urea channel protein inhibitors
  • Application of urea channel protein inhibitors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1, Screening and Pharmacodynamic Evaluation of UT-B Inhibitors

[0045] 1. Screening test method

[0046] 1) Take blood, put it in a 15ml graduated centrifuge tube (suspended in PBS containing sodium heparin), centrifuge at 3000r / min for 10min, discard the supernatant;

[0047] 2) Add the same amount of PBS as the blood, centrifuge at 3000r / min for 10min, discard the supernatant;

[0048] 3) Dilute red blood cells with hypertonic PBS containing 1.25M acetamide to a cell suspension with a specific volume of 2%;

[0049] 4) The erythrocyte suspension was incubated at room temperature for 2 hours to balance the concentration of acetamide inside and outside the cells, and mixed with a pipette at regular intervals;

[0050] 5) Take 99 μl of the above red blood cell suspension and place it in each well of a 96-well round-bottom microplate, then add 1 μl of the compound to be tested (such as Unisys), mix well, and incubate at room temperature for 6 minutes (the final...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of a urea transporter (UT) inhibitor Youli, of which the structural formula is represented as (I). In the invention, by means of erythrocyte model screening, the compound inhibiting the UT is obtained. An experimental result proves that the compounds, such as the Youli, can inhibit the permeability of urea through erythrocytes membrane induced by the UT-B, wherein the effect of the Youli has a dosage dependent relationship. In an effective dosage range, the Youli is free of cyto-toxicity on MDCK cells, which proves that the effect of inhibition the permeability of the urea through cells by the Youli is independent of the cyto-toxicity. The Youli is gradually enhanced in the inhibition effect on the UT-B and the inhibition effect of the Youli on the UT-B is reversible. An in-vivo test result proves that the Youli can significantly increase the urine output of mice, can reduce the concentration of urea in the urine of mice and can reduce the osmotic pressure, so that it is proves that the Youli has a urea-selective diuretic effect in-vivo.

Description

technical field [0001] The invention relates to the application of Youli, a urea channel protein inhibitor. Background technique [0002] 1. Current applications and R&D hotspots of diuretics [0003] Diuretics act on the kidneys to increase water excretion. Clinically, it is mainly used to treat edema caused by various reasons, and it can also be used to treat some non-edematous diseases. For example, as a first-line drug, it can be used alone or in combination with other drugs to treat hypertension, reduce the incidence of cardiovascular and cerebrovascular diseases and mortality Rate. Currently, the commonly used diuretics are mainly divided into three categories: high-potency diuretics, moderate-potency diuretics, and low-potency diuretics. High-potency diuretics and moderate-potency diuretics mainly inhibit Na + / K + / 2Cl - common transporter and distal convoluted tubule Na + / Cl - Common transporter, inhibits the reabsorption of NaCl, reduces the urine concentr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4709A61K31/5377A61K31/496A61K31/55A61K31/4725A61K31/4985A61P7/10
Inventor 杨宝学李飞周虹雷天落李敏
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap